AxioMed Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Private

  • Employees
  • 16

Employees

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 16

AxioMed General Information

Description

Developer of spinal function products intended to provide spinal implants that will address the unmet needs of degenerative disc disease patients. The company's spinal function products are freedom cervical disc and freedom lumbar disc help in spinal implants and disc replacement and it also offers expertise including early artificial disc development efforts, enabling the healthcare industry to advance the standard of care beyond fusion and first-generation artificial discs.

Contact Information

Website
www.axiomed.com
Formerly Known As
AxioMed Spine
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Therapeutic Devices
Primary Office
  • 350 Main Street
  • 2nd Floor
  • Malden, MA 02148
  • United States
+1 (978) 000-0000

AxioMed Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AxioMed Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore AxioMed‘s full profile, request access.

Request a free trial

AxioMed Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of spinal function products intended to provide spinal implants that will address the unmet needs of degenerat
Therapeutic Devices
Malden, MA
16 As of 2023
000.00
0000000 0000 000.00

000000

iscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
00000000000 0000000
Reno, NV
00 As of 0000
000000000 -

00000

Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliqu
00000000000 0000000
Cirencester, United Kingdom
000 As of 0000
000.00
000000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AxioMed Competitors (33)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Orthopaedic Implant Company Angel-Backed Reno, NV 00 000000000 -
00000 00000 Private Equity-Backed Cirencester, United Kingdom 000 000.00 000000000000
00000000 000000000 Corporation Turku, Finland 00 0000000000
000000 (0000000000 Venture Capital-Backed Helotes, TX 00 00.000 000000000000 00.000
00000000000 Formerly VC-backed Vigneux-de-Bretage, France 00 00.000 000000&0 00.000
You’re viewing 5 of 33 competitors. Get the full list »

AxioMed Patents

  • 57

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 8

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

AxioMed Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210052394-A1 Artificial disk with sensors Active 29-Sep-2017 000000000
US-10765527-B2 Artificial disk with sensors Active 29-Sep-2017 000000000
US-20190099276-A1 Artificial disk with sensors Active 29-Sep-2017 000000000 0
US-11504246-B2 Artificial disk with sensors Active 29-Sep-2017 000000000 00
US-20230082640-A1 Artificial disk with sensors Pending 29-Sep-2017 A61F2/442
To view AxioMed’s complete patent history, request access »

AxioMed Executive Team (10)

Name Title Board Seat Contact Info
Ken Yamada Chief Executive Officer & President
Nancy Rubin Co-Chief Financial Officer
Charles Birchall Co-Founder
Edward Benzel Co-Founder
Aditya Humad Co-Founder & Co-Chief Financial Officer
You’re viewing 5 of 10 executive team members. Get the full list »

AxioMed Board Members (8)

Name Representing Role Since
00000000 0000 00 Self Chairman 000 0000
You’re viewing 1 of 8 board members. Get the full list »

AxioMed Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AxioMed Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore AxioMed‘s full profile, request access.

Request a free trial